Skip to main content

Aridis Pharmaceuticals, Inc.

ARDSDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001614067

Aridis Pharmaceuticals, Inc. was delisted in 2025; its insiders filed their last Form 4 on Jun 28, 2024; 1 institution reported holding it in 13F filings for Q3 2025, worth $3 in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
1
Q3 2025, +1 vs. previous quarter
13F value
$3
Reported value at the end of Q3 2025
Superinvestors holding
0
At the end of Q3 2025

Superinvestors holding ARDS, Q3 2025

Go to the superinvestors tab

No superinvestor reported holding ARDS at the end of Q3 2025.

Latest insider trades

Open-market purchases and sales by Aridis Pharmaceuticals, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 28, 2024 (view filing)7:32 PM ETJun 244 daysLatePatzer EricDirectorPPurchaseCommon stock purchase+714.3K$0.07+$50.0K+419.4%884.6K after
Jun 28, 2024 (view filing)7:29 PM ETJun 244 daysLateTruong VuCEOPPurchaseCommon stock purchase+714.3K$0.07+$50.0K+107.5%1.38M after
Sep 8, 2021 (view filing)Sep 3-75 daysJafri HasanChief Medical OfficerPPurchase+5.10K$4.15+$21.1KNew position5.10K after3 lots
Jul 27, 2021 (view filing)Jul 27Same dayHamilton John FDirectorPPurchase+2.00K$4.87+$9.74KNew position2.00K after
Jul 27, 2021 (view filing)Jul 27Same dayTruong VuCEOPPurchase+5.00K$5.11+$25.6K+0.7%737.4K after
Jul 27, 2021 (view filing)Jul 27Same dayPatzer EricDirectorPPurchase+5.17K$4.84+$25.0K+0.7%702.1K after

Top 10 13F holders, Q3 2025

The largest institutional positions in Aridis Pharmaceuticals, Inc. at the end of Q3 2025; share changes are against Q2 2025.

See all 1 holders
Institutions holding ARDS in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Strengthening Families & Communities, LLC3,000$30.00%+3,000New